论文部分内容阅读
目的探讨静脉用人免疫球蛋白治疗手足口病的临床效果。方法随机抽取2010年12月～2011年12月我院收治的56例手足口病患儿的临床材料,将其分为两组,对照组26例,观察组30例,分别采用常规治疗和联合静脉用人免疫球蛋白治疗。治疗一周后,比较两组的治疗效果及症状消失时间。结果观察组总有效率为96.7%,观察组显著高于对照组的73.1%,差异具有统计学意义(P<0.05)。结论临床采用常规方法联合人免疫球蛋白,可以明显提高治疗手足口病的临床疗效,有效促进患儿的恢复,提升痊愈率。
Objective To investigate the clinical effect of intravenous human immunoglobulin in the treatment of hand, foot and mouth disease. Methods 56 cases of hand, foot and mouth disease in our hospital from December 2010 to December 2011 were randomly divided into two groups: control group (26 cases) and observation group (30 cases), respectively. The patients were treated with routine treatment and combination Intravenous immunoglobulin treatment. After a week of treatment, the treatment effect and symptom disappearance time were compared between the two groups. Results The total effective rate of observation group was 96.7%, the observation group was significantly higher than the control group of 73.1%, the difference was statistically significant (P <0.05). Conclusion Clinical routine combined with human immunoglobulin, can significantly improve the clinical curative effect of treatment of hand, foot and mouth disease, effectively promote the recovery of children and improve the cure rate.